Nov 30, 2022 / 06:50PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this afternoon. A pleasure to have with us the team from Agilent. We have CEO, Mike McMullen; CFO, Bob McMahon; from Investor Relations, we have Parmeet Ahuja and Mark (inaudible) in the background.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics TeamSo maybe you could kick got things off, Mike. It's been a remarkable 2 years not just for Agilent, but the spaces in being general. But I didn't think that Agilent was really, really strong. I mean, you've gone from strength to strength. If you could just recap what's happened, what surprised you? And then we can enter Q&A.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director